marketwatch
Pfizer’s stock falls despite fourth-quarter revenue and earnings beat. This analyst expects growth to accelerate.
MarketWatch • 2 MONTHS AGO
Regeneron’s earnings boosted by more than doubling of U.S. sales of blockbuster eye drug Eylea
MarketWatch • 2 MONTHS AGO
Archer Daniels Midland draws dreaded ‘sell’ rating despite laying off hundreds
MarketWatch • 2 MONTHS AGO
PayPal posts an earnings beat, but another metric is weighing on its stock
MarketWatch • 2 MONTHS AGO
The end of insurance: Climate change is destroying homeowners and insurers
MarketWatch • 2 MONTHS AGO
Merck’s struggles with HPV vaccine send stock to worst selloff in almost 17 years
MarketWatch • 2 MONTHS AGO
Trump has two strong options to defuse the U.S. debt time-bomb. He should use them.
MarketWatch • 2 MONTHS AGO